Showing results 6 to 25 of 55
< previous
next >
| Issue Date | Title | Sub-Title | Author(s) | Journal Name | Volume Number | Issue Number | Pages |
| 2016 | Does environmental regulation indirectly induce upstream innovation? New evidence from India. What's new in the economics of innovation? Theory, empirics and public policy | - | Chakraborty, Pavel ; Chatterjee, Chirantan | | | | |
| 2012 | Early stage pharmaceutical innovation and generic entry | - | Chatterjee, Chirantan | | | | |
| 12-Sep-2011 | Entrepreneurship and capability development in Indian bio-pharmaceuticals: An empirical investigation behind the formation of an R&D intensive emerging economy sector | - | Chatterjee, Chirantan | | | | |
| 2013 | Ethical issues in health care sector in India | - | Chatterjee, Chirantan ; Srinivasan, Vasanthi | IIMB Management Review | Vol.25 | Iss.1 | 49-62p. |
| 2012 | Evolution of global innovation network in MNEs | - | Chatterjee, Chirantan ; Jha, Srivardhini K ; Krishnan, Rishikesha T | | | | |
| 2014 | Faculty invitee | - | Chatterjee, Chirantan | | | | |
| 2013 | Faculty invitee, 1st Google-India Faculty Summit 2013 | - | Chatterjee, Chirantan | | | | |
| 2014 | Faculty invitee: How do incumbents respond to low-end firm entry? | - | Chatterjee, Chirantan | | | | |
| 2013 | First mover advantages & TRIPS | - | Chatterjee, Chirantan | | | | |
| 2016 | First-mover advantages before and after TRIPS: Evidence from the Indian pharmaceutical industry | - | Chatterjee, Chirantan ; Bhaskarabhatla, Ajay | | | | |
| 25-Dec-2015 | From labs to markets, the emerging market for biological drugs in India | - | Chatterjee, Chirantan | India Abroad | | | |
| 2018 | Gender and its rising role in modern Indian innovation and entrepreneurship | - | Chatterjee, Chirantan ; Ramu, Swapnika | IIMB Management Review | Vol.30 | Iss.1 | 62-72p. |
| 2018 | Government health insurance and spatial peer effects: new evidence from India | - | Chatterjee, Chirantan ; Joshi, Chirantan ; Sood, Neeraj ; Boregowda, P | Social Science and Medicine | Vol.196 | | 131-141p. |
| 2014 | Guest lecturer: Innovation & Growth in India | - | Chatterjee, Chirantan | | | | |
| 2016 | Hit where it hurts: Cartel policing using targeted sales and supply embargoes | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan ; Karreman, Bas | Journal of Law and Economics | Vol.59 | Iss.4 | 805-846p. |
| 2013 | How do incumbents respond to bottom-of-the-pyramid firm entry? | - | Chatterjee, Chirantan ; Bhaskarabhatla, Ajay | | | | |
| 2016 | Improving investor-investee matches with regulation: evidence from the orphan drug act and global biotechnology industry | - | Kim, Yujin ; Chatterjee, Chirantan | | | | 42p. |
| 23-Apr-2016 | India will have to decide whether it wants to get serious about R&D by taking IPR seriously | - | Chatterjee, Chirantan | The Economic Times | | | |
| 2014 | Innovation and internationalisation in the Indian software industry: Wipro – Going forward: Interview with Rishad Premji, Chief Strategy Officer, Wipro Limited | - | Chatterjee, Chirantan | IIMB Management Review | Vol.26 | Iss.1 | 59-64p. |
| 2013 | Invited as a panelist; 'India as a pioneer of innovation: Constraints and opportunities' | - | Chatterjee, Chirantan | | | | |
